We are live on ! Find out more
Bank of New York Mellon

Bank of New York Mellon Portfolio holdings

AUM $609B
1-Year Est. Return 40.19%
 

Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.

This Fund
S&P 500
This Quarter Est. Return
+4.98%
1 Year Est. Return
+40.19%
3 Year Est. Return
+118.86%
5 Year Est. Return
+156%
10 Year Est. Return
+606.23%
AUM
$347B
AUM Growth
+$11.3B
Cap. Flow
-$1.57B
Cap. Flow %
-0.45%
Top 10 Hldgs %
12.67%
Holding
4,430
New
161
Increased
2,590
Reduced
1,402
Closed
170

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$714M
2
IBM icon
IBM
IBM
+$395M
3
CSCO icon
Cisco
CSCO
+$303M
4
PG icon
Procter & Gamble
PG
+$290M
5
M icon
Macy's
M
+$237M

Sector Composition

Rank Sector Weight
1 Technology 15.6%
2 Financials 14.73%
3 Healthcare 12.36%
4 Industrials 10.02%
5 Consumer Discretionary 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LRMR icon
3601
Larimar Therapeutics
LRMR
$454M
$313K ﹤0.01%
8,200
+2,422
+42% +$98.2K
ACU icon
3602
Acme United Corp
ACU
$228M
$311K ﹤0.01%
12,165
-823
-6% -$17.9K
NL icon
3603
NLI Holdings
NL
$329M
$311K ﹤0.01%
38,178
+3,789
+11% +$20.7K
LUB
3604
DELISTED
Luby's Inc.
LUB
$310K ﹤0.01%
72,471
+11,807
+19% +$50K
HSBC.PRA
3605
DELISTED
HSBC Holdings PLC, Inc. ADS(1/40 shr. 6.2% Non-Cum. Dlr. Pref. Shrs., Ser.A)
HSBC.PRA
$309K ﹤0.01%
+12,274
New +$313K
ASX icon
3606
ASE Group
ASX
$103B
$307K ﹤0.01%
60,678
-743
-1% -$4.13K
MITL
3607
DELISTED
Mitel Networks Corporation
MITL
$304K ﹤0.01%
44,842
XRM
3608
DELISTED
Xerium Technologies Inc (new)
XRM
$303K ﹤0.01%
53,880
-13,300
-20% -$88K
APU
3609
DELISTED
AmeriGas Partners, L.P.
APU
$301K ﹤0.01%
6,279
-1,423
-18% -$65.2K
FBRC
3610
DELISTED
FBR & Co. Common Stock
FBRC
$300K ﹤0.01%
23,029
-9,120
-28% -$118K
RGLS
3611
DELISTED
Regulus Therapeutics
RGLS
$299K ﹤0.01%
1,110
-30
-3% -$9.75K
BPT
3612
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$298K ﹤0.01%
12,564
-4,408
-26% -$97K
WIP icon
3613
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$474M
$298K ﹤0.01%
5,728
+537
+10% +$28.9K
MMT
3614
Aberdeen Multi-Market Income Fund
MMT
$244M
$297K ﹤0.01%
+49,087
New +$291K
TTOO
3615
DELISTED
T2 Biosystems, Inc
TTOO
$296K ﹤0.01%
11
+2
+22% +$61.6K
TUZ
3616
DELISTED
PIMCO 1-3 Year U.S. Treasury Index Exchange-Traded Fund
TUZ
$296K ﹤0.01%
+5,852
New +$297K
PN
3617
DELISTED
Patriot National, Inc.
PN
$296K ﹤0.01%
63,527
+27,481
+76% +$181K
FDIQ
3618
Invesco Bloomberg Financial Data Providers ETF
FDIQ
$49M
$291K ﹤0.01%
5,208
+207
+4% +$10.3K
AST
3619
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$291K ﹤0.01%
63,320
+1,727
+3% +$7.13K
ARGS
3620
DELISTED
Argos Therapeutics, Inc.
ARGS
$291K ﹤0.01%
2,971
-1
-0% -$94
IRIX icon
3621
IRIDEX
IRIX
$14.3M
$288K ﹤0.01%
20,466
+596
+3% +$8.46K
PVBC
3622
DELISTED
Provident Bancorp
PVBC
$286K ﹤0.01%
32,326
+4,228
+15% +$36.1K
FBIO icon
3623
Fortress Biotech
FBIO
$91.4M
$284K ﹤0.01%
6,993
-1,508
-18% -$56.4K
PRCP
3624
DELISTED
Perceptron Inc
PRCP
$283K ﹤0.01%
42,600
-437
-1% -$2.81K
DAC icon
3625
Danaos Corp
DAC
$2.55B
$282K ﹤0.01%
7,601
+51
+0.7% +$1.99K

Similar funds

Bank of New York Mellon's Q4 2016 Portfolio in Review

As of Q4 2016, Bank of New York Mellon held 4,430 positions worth $347B, up 3.3% from $336B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Bank of New York Mellon's Q4 2016 filing shows 161 new, 2,590 increased, 1,402 reduced and 170 closed positions. Its largest new stake was Lamb Weston: 2,449,932 shares worth $92.7M. The largest sale was Merck, an estimated $714M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

  • Bank of New York Mellon's largest Q4 2016 buy was Lamb Weston: 2,449,932 shares worth $92.7M.
  • Bank of New York Mellon added most to CME Group in Q4 2016, an estimated $322M increase.
  • Bank of New York Mellon's biggest Q4 2016 reduction was Merck, cutting an estimated $714M.
  • Bank of New York Mellon fully exited LinkedIn Corporation in Q4 2016, selling an estimated $82.8M.
  • Bank of New York Mellon's ten largest holdings make up 13% of its $347B portfolio in Q4 2016.
  • Bank of New York Mellon opened 161 new positions and closed 170 in Q4 2016.
  • Bank of New York Mellon's portfolio value rose 3.3% quarter-over-quarter to $347B.

Based on Bank of New York Mellon's 13F filing for Q4 2016, filed 13 Feb 2017.